Bagalanon, Elenita V.
HRN: 16-44-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/20/2026
05/27/2026
IV
500mg
Q8H
DM FOOT
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes